199 related articles for article (PubMed ID: 25291526)
1. Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study.
Halfdanarson TR; Bamlet WR; McWilliams RR; Hobday TJ; Burch PA; Rabe KG; Petersen GM
Pancreas; 2014 Nov; 43(8):1219-22. PubMed ID: 25291526
[TBL] [Abstract][Full Text] [Related]
2. Diabetes, smoking, alcohol use, and family history of cancer as risk factors for pancreatic neuroendocrine tumors: a systematic review and meta-analysis.
Haugvik SP; Hedenström P; Korsæth E; Valente R; Hayes A; Siuka D; Maisonneuve P; Gladhaug IP; Lindkvist B; Capurso G
Neuroendocrinology; 2015; 101(2):133-42. PubMed ID: 25613442
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Sporadic Pancreatic Neuroendocrine Tumors: A Case-Control Study.
Ben Q; Zhong J; Fei J; Chen H; Yv L; Tan J; Yuan Y
Sci Rep; 2016 Oct; 6():36073. PubMed ID: 27782199
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
Yadav S; Sharma P; Zakalik D
Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors.
Cigrovski Berković M; Catela Ivković T; Marout J; Zjačić-Rotkvić V; Kapitanović S
DNA Cell Biol; 2012 Apr; 31(4):531-6. PubMed ID: 21988351
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology and risk factors of pancreatic cancer.
Capasso M; Franceschi M; Rodriguez-Castro KI; Crafa P; Cambiè G; Miraglia C; Barchi A; Nouvenne A; Leandro G; Meschi T; De' Angelis GL; Di Mario F
Acta Biomed; 2018 Dec; 89(9-S):141-146. PubMed ID: 30561407
[TBL] [Abstract][Full Text] [Related]
7. Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms.
Valente R; Hayes AJ; Haugvik SP; Hedenström P; Siuka D; Korsæth E; Kämmerer D; Robinson SM; Maisonneuve P; Delle Fave G; Lindkvist B; Capurso G
Endocr Relat Cancer; 2017 Aug; 24(8):405-414. PubMed ID: 28566532
[TBL] [Abstract][Full Text] [Related]
8. Risk factors associated with neuroendocrine tumors: A U.S.-based case-control study.
Hassan MM; Phan A; Li D; Dagohoy CG; Leary C; Yao JC
Int J Cancer; 2008 Aug; 123(4):867-73. PubMed ID: 18491401
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors in Pancreatic Adenocarcinoma: the Interrelation with Familial History and Predictive Role on Survival.
Petrusel L; Bilibou M; Drug V; Leucuta DC; Seicean R; Cainap C; Seicean A
J Gastrointestin Liver Dis; 2020 Sep; 29(3):391-398. PubMed ID: 32919422
[TBL] [Abstract][Full Text] [Related]
10. Etiological Observations in Seven Patients with Pancreatic Neuroendocrine Tumors (PNETs).
Landin J; Weber W
In Vivo; 2016; 30(2):147-8. PubMed ID: 26912826
[TBL] [Abstract][Full Text] [Related]
11. The up-to-date review of epidemiological pancreatic neuroendocrine tumors in Japan.
Ito T; Lee L; Hijioka M; Kawabe K; Kato M; Nakamura K; Ueda K; Ohtsuka T; Igarashi H
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):574-7. PubMed ID: 25689058
[TBL] [Abstract][Full Text] [Related]
12. Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study.
Zhu LM; Tang L; Qiao XW; Wolin E; Nissen NN; Dhall D; Chen J; Shen L; Chi Y; Yuan YZ; Ben QW; Lv B; Zhou YR; Bai CM; Chen J; Song YL; Song TT; Lu CM; Yu R; Chen YJ
Medicine (Baltimore); 2016 Feb; 95(7):e2836. PubMed ID: 26886644
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk.
Karakaxas D; Gazouli M; Coker A; Agalianos C; Papanikolaou IS; Patapis P; Liakakos T; Dervenis C
Med Oncol; 2014 Oct; 31(10):241. PubMed ID: 25213764
[TBL] [Abstract][Full Text] [Related]
14. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
Kuo EJ; Salem RR
Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
[TBL] [Abstract][Full Text] [Related]
15. Risk and Protective Factors for Small Intestine Neuroendocrine Tumors: A Prospective Case-Control Study.
Rinzivillo M; Capurso G; Campana D; Fazio N; Panzuto F; Spada F; Cicchese N; Partelli S; Tomassetti P; Falconi M; Delle Fave G
Neuroendocrinology; 2016; 103(5):531-7. PubMed ID: 26356731
[TBL] [Abstract][Full Text] [Related]
16. Diabetes Is Associated With the Metastasis of Pancreatic Neuroendocrine Tumors.
Fan Z; Gong Y; Huang Q; Yang C; Cheng H; Jin K; Fan K; Ni Q; Yu X; Luo G; Liu C
Pancreas; 2020 Jul; 49(6):751-756. PubMed ID: 32541629
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for intraductal papillary mucinous neoplasm (IPMN) of the pancreas: a multicentre case-control study.
Capurso G; Boccia S; Salvia R; Del Chiaro M; Frulloni L; Arcidiacono PG; Zerbi A; Manta R; Fabbri C; Ventrucci M; Tarantino I; Piciucchi M; Carnuccio A; Boggi U; Leoncini E; Costamagna G; Delle Fave G; Pezzilli R; Bassi C; Larghi A; ;
Am J Gastroenterol; 2013 Jun; 108(6):1003-9. PubMed ID: 23458848
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.
Halfdanarson TR; Rabe KG; Rubin J; Petersen GM
Ann Oncol; 2008 Oct; 19(10):1727-33. PubMed ID: 18515795
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic neuroendocrine tumors.
Varas Lorenzo M; Cugat Andorra E; Capdevila Castillón J
Rev Esp Enferm Dig; 2017 Jun; 109(6):480-481. PubMed ID: 28253729
[TBL] [Abstract][Full Text] [Related]
20. Cystic pancreatic neuroendocrine tumors: A more favorable lesion?
Carr RA; Bletsis P; Roch AM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM; Ceppa EP
Pancreatology; 2019 Mar; 19(2):372-376. PubMed ID: 30704851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
